View More
Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education.
Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.
In this episode, David A. Wohl, MD, discusses current guidelines and clinical trial data informing optimal selection of first-line antiretroviral therapy for HIV.
David A. Wohl, MD
Professor of Medicine
School of Medicine
Site Leader, AIDS Clinical Trials Unit-Chapel Hill
University of North Carolina at Chapel Hill
Director, North Carolina AIDS Training and Education Center
Chapel Hill, North Carolina
Co-Director, HIV Services
North Carolina Department of Correction
Raleigh, North Carolina
Contact Clinical Care Options
For customer support please email: customersupport@cealliance.com
Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191
On-demand Clinical Care Options (CCO) webcast: HIV expert roundtable on current and emerging HIV prevention strategies and addressing disparities in health equity
Babafemi Taiwo, MBBS
Daniel R. Kuritzkes, MD
Darcy Wooten, MD
Released: October 26, 2021
Silvia Petretti on individualizing antiretroviral therapy according to patient factors from Clinical Care Options
Silvia Petretti
Released: October 22, 2021
Clinical Care Options (CCO) expert analysis of new HIV data from IDWeek 2021, provided by expert HIV faculty
Eric S. Daar, MD
Released: October 21, 2021
Expert selections of important HIV data from IDWeek 2021, including current and investigational ART, HIV PrEP, and metabolic outcomes of ART.
Eric S. Daar, MD
Darcy Wooten, MD
Released: October 19, 2021
You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.